New Treatments Developed in Open Innovation Program
The University of Cambridge website reported that Cambridge researchers are developing new therapies as part of a collaborative program with industry. Two revolutionary treatments which could alleviate pain in people with hypersensitivity to heat, and provide a new regenerative therapy with MS sufferers, are being developed by University of Cambridge researchers at Stevenage Bioscience Catalyst, the UK’s first open innovation bioscience campus. The program gives University researchers access to the drug development expertise of GSK and other pharmaceutical companies, while giving industry access to Cambridge research and know-how, in order to accelerate the development of new medicines.
Click here to read the full article.